News AxoGen, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
5.87 ^USD	+0.69%		-10.52%	-14.06%

May. 02	Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024
May. 02	Earnings Flash (AXGN) AXOGEN Posts Q1 Revenue $41.4M, vs. Street Est of $42.1M	MT

Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
Earnings Flash (AXGN) AXOGEN Posts Q1 Revenue $41.4M, vs. Street Est of $42.1M	May. 02	MT
AxoGen: Q1 Earnings Snapshot	May. 02	AQ
Axogen, Inc Reports First Quarter 2024 Financial Results	May. 02	GL
Axogen, Inc Reports First Quarter 2024 Financial Results	May. 02	AQ
AxoGen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Axogen, Inc. Provides Revenue Guidance for the Year 2024	May. 02	CI
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™	Apr. 29	GL
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix	Apr. 29	CI
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	Apr. 16	GL
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	Apr. 16	AQ
Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing	Mar. 08	MT
AxoGen, Inc. Announces Executive Changes	Mar. 08	CI
AxoGen Files $100 Million Mixed-Securities Shelf	Mar. 06	MT
Health Care Down After Mixed Earnings -- Health Care Roundup	Mar. 05	DJ
Transcript : AxoGen, Inc., Q4 2023 Earnings Call, Mar 05, 2024	Mar. 05
AxoGen: Q4 Earnings Snapshot	Mar. 05	AQ
AxoGen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results	Mar. 05	GL
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results	Mar. 05	AQ

No results for this search